5-Hydroxyindole acetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment.
D000328:Adult; D000367:Age Factors; D000368:Aged; D001714:Bipolar Disorder / Q000097:blood / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D001835:Body Weight; D002986:Clinical Trials as Topic; D005260:Female; D006207:Half-Life; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011339:Probenecid / Q000097:blood / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D011485:Protein Binding; D012044:Regression Analysis; D013223:Statistics as Topic; D013997:Time Factors
D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D011339:Probenecid; D006719:Homovanillic Acid